Howell Peyton R's Form 4 filing
Tandem Diabetes Care Inc (TNDM) · filed May 10, 2022
- Accession no.
- 0001438133-22-000067
- Filed
- May 10, 2022
- Trade date
- May 6, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions. Open-market purchases total $149.7K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Howell Peyton RCIK 0001528056 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 6, 2022 | Common Stock | PPurchaseAcquired | +100 | $75.21 | +$7,521 | 1,048 | Direct | |
| May 6, 2022 | Common Stock | PPurchaseAcquired | +17 | $74.57 | +$1,267.69 | 1,065 | Direct | |
| May 6, 2022 | Common Stock | PPurchaseAcquired | +500 | $74.60 | +$37,300 | 1,565 | Direct | |
| May 6, 2022 | Common Stock | PPurchaseAcquired | +400 | $75.21 | +$30,084 | 1,965 | Direct | |
| May 6, 2022 | Common Stock | PPurchaseAcquired | +500 | $75.00 | +$37,500 | 2,465 | Direct | |
| May 6, 2022 | Common Stock | PPurchaseAcquired | +483 | $74.58 | +$36,022.14 | 2,948 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.